ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Statistics

Total Valuation

ALXO has a market cap or net worth of $260.58 million. The enterprise value is $230.56 million.

Market Cap	260.58M
Enterprise Value	230.56M

Important Dates

The last earnings date was Friday, February 27, 2026, before market open.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

ALXO has 131.61 million shares outstanding. The number of shares has increased by 2.84% in one year.

Current Share Class	131.61M
Shares Outstanding	131.61M
Shares Change (YoY)	+2.84%
Shares Change (QoQ)	+1.32%
Owned by Insiders (%)	1.23%
Owned by Institutions (%)	21.03%
Float	104.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.23
P/TBV Ratio	10.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.57.

Current Ratio	2.07
Quick Ratio	1.84
Debt / Equity	0.57
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-62.95

Financial Efficiency

Return on equity (ROE) is -145.70% and return on invested capital (ROIC) is -76.74%.

Return on Equity (ROE)	-145.70%
Return on Assets (ROA)	-60.95%
Return on Invested Capital (ROIC)	-76.74%
Return on Capital Employed (ROCE)	-292.37%
Weighted Average Cost of Capital (WACC)	7.09%
Revenue Per Employee	n/a
Profits Per Employee	-$2.31M
Employee Count	44
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +105.86% in the last 52 weeks. The beta is 0.50, so ALXO's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+105.86%
50-Day Moving Average	1.85
200-Day Moving Average	1.28
Relative Strength Index (RSI)	45.23
Average Volume (20 Days)	741,567

Short Selling Information

The latest short interest is 1.17 million, so 0.89% of the outstanding shares have been sold short.

Short Interest	1.17M
Short Previous Month	1.17M
Short % of Shares Out	0.89%
Short % of Float	1.13%
Short Ratio (days to cover)	1.69

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-100.85M
Pretax Income	-101.70M
Net Income	-101.70M
EBITDA	-100.14M
EBIT	-100.85M
Earnings Per Share (EPS)	-$1.90

Balance Sheet

The company has $44.79 million in cash and $14.77 million in debt, with a net cash position of $30.02 million or $0.23 per share.

Cash & Cash Equivalents	44.79M
Total Debt	14.77M
Net Cash	30.02M
Net Cash Per Share	$0.23
Equity (Book Value)	25.98M
Book Value Per Share	0.48
Working Capital	26.17M

Cash Flow

In the last 12 months, operating cash flow was -$84.14 million and capital expenditures -$212,000, giving a free cash flow of -$84.35 million.

Operating Cash Flow	-84.14M
Capital Expenditures	-212,000
Free Cash Flow	-84.35M
FCF Per Share	-$0.64

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALXO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.84%
Shareholder Yield	-2.84%
Earnings Yield	-39.03%
FCF Yield	-32.37%

Analyst Forecast

The average price target for ALXO is $3.00, which is 51.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.00
Price Target Difference	51.52%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2